BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Thermo Fisher Scientific and CZ Imaging Institute Forge Alliance to Advance High-Resolution Cellular Imaging

New alliance for advanced biological imaging aimed at enhancing some of the world's most innovative structural cell biology capabilities to help scientists...

March 28, 2025 | News

Aperbio Technologies Launches APAC Headquarters in Singapore to Accelerate Precision Life Sciences

Aperbio Technologies is proud to announce the grand opening of its Asia-Pacific (APAC) regional office in Singapore — a landmark milestone in the com...

March 26, 2025 | News

Harbour BioMed and AstraZeneca Announce $4.6B Global Collaboration on Next-Gen Multi-Specific Antibodies

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...

March 24, 2025 | News

Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation

What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...

March 14, 2025 | Interaction

SPRIM Global Investments and OneIM Launch $300M Joint Venture to Accelerate Clinical Trial Financing

SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and On...

March 11, 2025 | News

Taiwan’s TCI Biotech Reports Strong 2024 Financial Results, Driving Innovation and Global Expansion

TCI Biotech, a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year endin...

March 11, 2025 | Company results

Nona Biosciences Unveils AI-Powered Hu-mAtrIx™ Platform to Transform Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-...

March 10, 2025 | News

Merck Reports Strong 2024 Growth with €21.2 Billion in Sales, Projects Continued Expansion in 2025

Merck, a leading science and technology company, has delivered profitable growth in fiscal year 2024, demonstrating resilience and strategic execution acro...

March 07, 2025 | Company results

GenAssist Gains FDA IND Clearance for First-in-Class Base Editing Therapy for Duchenne Muscular Dystrophy

GenAssist Ltd (GenAssist), a pioneering gene-editing biotechnology company specializing in genome medicines, is thrilled to announce that it has received&n...

March 07, 2025 | News

Akeso Completes Patient Enrollment for Phase III Trial of Cadonilimab as Adjuvant Therapy for Hepatocellular Carcinoma

Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinic...

March 06, 2025 | News

Merck Life Science Expands in Japan with New Tokyo Office

Merck Life Science, a global leader in the life sciences sector, has strengthened its commitment to the Japanese market with the inauguration of a new offi...

March 06, 2025 | News

Raziel Therapeutics Launches Phase 3 Study in China for RZL-012, an Injectable Fat Reduction Treatment

Raziel Therapeutics, a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market, announces phas...

March 05, 2025 | News

WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...

March 04, 2025 | News

MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform

MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...

March 04, 2025 | News

Stay Connected